Please use this identifier to cite or link to this item: https://scholarbank.nus.edu.sg/handle/10635/110365
Title: Toll-like receptor 2: Therapeutic target for gastric carcinogenesis
Authors: McCormack, W.
Oshima, M.
Tan, P. 
Jenkins, B.J.
Keywords: antineoplastic agent
cisplatin
epirubicin
fluorouracil
myeloid differentiation factor 88
opn 301
small interfering RNA
toll like receptor 2
unclassified drug
advanced cancer
antineoplastic activity
cancer inhibition
cancer recurrence
cancer size
cancer survival
chronic inflammation
drug efficacy
drug mechanism
drug safety
editorial
gene amplification
gene overexpression
gene targeting
human
intracellular signaling
nonhuman
overall survival
somatic mutation
stomach cancer
stomach carcinogenesis
strategic planning
survival rate
toll like receptor 2 gene
upregulation
Issue Date: 2012
Publisher: Impact Journals LLC
Citation: McCormack, W., Oshima, M., Tan, P., Jenkins, B.J. (2012). Toll-like receptor 2: Therapeutic target for gastric carcinogenesis. Oncotarget 3 (11) : 1260-1261. ScholarBank@NUS Repository.
Rights: Attribution 4.0 International
Source Title: Oncotarget
URI: http://scholarbank.nus.edu.sg/handle/10635/110365
ISSN: 19492553
Rights: Attribution 4.0 International
Appears in Collections:Staff Publications
Elements

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_18632_oncotarget_735.pdf437.06 kBAdobe PDF

OPEN

PublishedView/Download

Google ScholarTM

Check


This item is licensed under a Creative Commons License Creative Commons